Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Evaluation of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa

NCT07109765 is registered in ClinicalTrials.gov with Peking Union Medical College as lead sponsor.

NCT NCT07109765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07109765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Evaluation of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa
Lead sponsor
Peking Union Medical College
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
June 1, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (hs)